Morphine Dosing in Newborns for Pain Relief
For pain relief in newborns, morphine should be administered at 0.05-0.1 mg/kg IV/IM every 4-6 hours as needed, with careful monitoring for respiratory depression and other adverse effects. 1
Dosing Considerations
- Morphine is one of the most commonly used opioids for persistent pain in newborns, with fentanyl being the other primary option 2
- Dosing should account for gestational age, as morphine clearance correlates positively with gestational age and birth weight 3
- Premature infants (<28 weeks gestational age) are at significantly higher risk for delayed severe apnea, even with low doses of morphine 4
- For continuous infusion in ventilated newborns, a loading dose of 50-75 μg/kg (0.05-0.075 mg/kg) followed by 10-30 μg/kg/hour (0.01-0.03 mg/kg/hour) is typically used 2
Route of Administration
- Intravenous (IV) is the preferred route for acute pain management in hospitalized newborns 2
- Intramuscular (IM) administration at 0.1 mg/kg can be used when IV access is not available 1
- Subcutaneous administration via specialized catheters (e.g., Insuflon) has been used successfully for longer-term pain management after major surgery in newborns 5
Monitoring and Safety Considerations
- Respiratory depression is the most significant risk; continuous monitoring of respiratory rate and oxygen saturation is essential 2
- Other adverse effects include hypotension, constipation, urinary retention, and decreased gastrointestinal motility 2, 6
- Higher morphine concentrations (187 ± 82 ng/mL) are associated with decreased gastrointestinal motility compared to lower concentrations (128 ± 51 ng/mL) 3
- Be prepared to administer naloxone (0.1 mg/kg IV/IM) for reversal of respiratory depression if needed 1
- Steady-state morphine plasma concentrations are achieved after 24-48 hours of continuous infusion 6
Special Considerations for Premature Infants
- Morphine clearance is significantly lower in premature infants, requiring dose reduction 3
- Even at doses less than half the recommended amount (0.025 mg/kg), premature infants can experience significant analgesia and sedation 4
- Infants <28 weeks gestational age are at particularly high risk for delayed severe apnea and require especially careful monitoring 4
Alternatives for Minor Procedures
- For minor procedures like heel lance or venipuncture, non-pharmacological methods should be considered first:
Caution with Prolonged Use
- Continuous opioid infusions in mechanically ventilated preterm infants may prolong the duration of mechanical ventilation 7
- Development of dependence and tolerance is a concern with prolonged use 2
- For infants requiring prolonged treatment, a weaning protocol should be implemented to prevent withdrawal symptoms 8